Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill / / edited by Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman
| Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill / / edited by Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Adis, , 2018 |
| Descrizione fisica | 1 online resource (X, 275 p. 22 illus., 9 illus. in color.) |
| Disciplina | 615.1 |
| Soggetto topico |
Chemotherapy
Pharmaceutical technology Pharmacotherapy Pharmaceutical Sciences/Technology |
| ISBN | 981-10-5336-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | 1. Basic Pharmacokinetic Principles -- 2. Antibiotic Pharmacodynamics -- 3. Physiological Manifestations of Critical Illness -- 4. Dosing in Obese Critically Ill Patients -- 5. Hypoalbuminemia and Altered Protein Binding -- 6. Antibacterial Pharmacokinetic/Pharmacodynamic Considerations in the Critically ill -- 7. Augmented Renal Clearance -- 8. Antibiotic Dosing During Extracorporeal Membrane Oxygenation -- 9. Therapeutic Drug Monitoring: More than Avoiding Toxicity -- 10. Generic and Optimised Antibacterial Dosing Strategies in the Critically Ill -- 11. Antifungal PK/PD in the Critically Ill -- 12. Antibiotic Dosing in Pediatric Critically Ill Patients -- 13. Antibiotic Stewardship in the Intensive Care Unit. |
| Record Nr. | UNINA-9910300451903321 |
| Singapore : , : Springer Singapore : , : Imprint : Adis, , 2018 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Feature Paper in Antibiotics for 2019
| Feature Paper in Antibiotics for 2019 |
| Autore | Lipman Jeffrey |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 |
| Descrizione fisica | 1 online resource (282 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
Acinetobacter baumannii
actinomycetes anti-Candida activity antibacterial antibacterials antibiotic prescribing antibiotic resistance antibiotic stewardship antibiotic utilization antibiotics Antibiotics antifungal antifungals antimicrobial resistance Antimicrobial resistance antimicrobial stewardship antimicrobials bacteriophages behavior change bioactivity biofilms biosynthesis broad-spectrum agents camphorimine carbapenem-resistant carbapenem-resistant Enterobacteriaceae chloramfenicol clinical trials cost-effectiveness analysis cost-utility analysis CRE days of therapy economic evaluation efflux inhibitors efflux pumps Enterobacteriaceae erm(41) extended-spectrum beta-lactamases florfenicol fluoroquinolones general practitioners guideline guidelines health equity assessment tool health inequalities hospital epidemiology HPLC-MS/MS implementation inappropriate prescribing infection control infection prevention infectious disease methicillin-resistant Staphylococcus aureus mutations mycobacteria n/a non-target feed novel antimicrobials One Health out-of-hours care phage therapy piperine piperlongumine policy analysis polyketide synthases polyketides practitioners cooperative primary care Pseudomonas aeruginosa public health quality improvement quality indicators quality of care resistance silver complexes Singapore stakeholder consultation Start Smart then Focus swine synergy thiamfenicol urinary tract infections validation verapamil |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557689603321 |
Lipman Jeffrey
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||